21 CFR 520.1803
§ 520.1803 Piperazine citrate capsules.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 520.1803, § 520.1803 Piperazine citrate capsules, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87278
- Permanent ID
ys:prov:87278@1- SHA-256
8de0ea6cef5236545af55935ac5972a08e163edaca1d4f8f373e537b4e8180bd
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each capsule contains piperazine citrate equivalent to 140 milligrams of piperazine base.
(b) Sponsor. See No. 021091 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs and cats—(1) Amount. The contents of 1 capsule should be mixed with the food of the animal for each 5 pounds, or fraction thereof of body weight, except dogs weighing over 25 pounds should be given the contents of 6 capsules. The drug should be mixed in 1/2 of the regular feeding and when the animal has finished eating the dosed food, the remainder of the food may be given. Dogs and cats may be wormed at 6 to 8 weeks of age. The first treatment should be repeated 10 days later. Reinfection may occur. Repeat treatment if indicated.
(2) Indications for use. For the removal of large roundworms (Toxocara canis and Toxascaris leonina).
(3) Limitations. Severely debilitated animals should not be treated except on the advice of a veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.